Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation.
Ryohei OnoKazutaka NishimuraHidehisa TakahashiYasuhiko HoriKenichi FukushimaYoshio KobayashiPublished in: Drugs in R&D (2022)
Creatinine clearance tends to be negatively correlated with trough AXA concentrations in patients with non-valvular atrial fibrillation taking edoxaban, while renal function is not correlated with peak AXA concentrations.